Immunome

Immunome, Inc. is a biotechnology company focused on discovering and developing first-in-class antibody therapeutics by leveraging its proprietary human memory B cell platform. They make money through the development and commercialization of novel cancer immunotherapies and infectious disease treatments. Founded in 2006, Immunome has a significant history of innovation, including a strategic partnership with Fox Chase Cancer Center and a successful IPO in 2020, which has bolstered their research and development capabilities.

Recent Posts by Immunome

1-20 of 126